Brief: Zylox-Tonbridge Medical Technology Announces Acquisition Of 49% Stake in Optimed Holding GmbH
16/01/2026 24:32
Jan 16 (Reuters) - Zylox-Tonbridge Medical Technology Co Ltd 2190.HK: ACQUISITION OF 49% EQUITY INTERESTS OPTIMED HOLDING GMBH DEAL FOR EUR18.375 MILLION Further company coverage: 2190.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY
See all newsChinese medical device maker Zylox-Tonbridge's revenue rises 31%, aided by global expansion
Brief: Zylox-Tonbridge Medical Technology Profit For Year Rmb244.4 Mln
Brief: Zylox-Tonbridge Medical Technology Sees Revenue More Than RMB1.05 Billion For Year
Brief: Zylox-Tonbridge Medical Technology Announces Acquisition Of 49% Stake in Optimed Holding GmbH
Brief: Zylox-Tonbridge Medical Technology Recommends Distribution Of Final Dividend Of RMB0.1 Per Share